Structure of an enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases

Cell

Volumn 89, Issue 6, 1997, Pages 887-895

  Hon, Wai Ching ^a   McKay, Geoffrey A ^a   Thompson, Paul R ^a   Sweet, Robert M ^b   Yang, Daniel S C ^a   Wright, Gerard D ^a   Berghuis, Albert M ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; PROTEIN KINASE;

ANTIBIOTIC RESISTANCE; ARTICLE; CRYSTAL STRUCTURE; ENZYME STRUCTURE; EUKARYOTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEQUENCE HOMOLOGY; X RAY DIFFRACTION;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 0030830868     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80274-3     Document Type: Article

References (60)

1. Benveniste, R., and Davies, J. (1973). Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc. Natl. Acad. Sci. USA 70, 2276-2280.
2. Bernstein, F.C., Koetzle, T.F., Williams, J.B., Meyer, E.F., Jr., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T., and Tasumi, M. (1977). The protein data bank: a computer-based archival file for macromolecular structure. J. Mol. Biol. 112, 535-542.
3. Bonomo, R.A., Dawes, C.G., Knox, J.R., and Shlaes, D.M. (1995). β-Lactamase mutations far from the active site influence inhibitor binding. Biochim. Biophys. Acta 1247, 121-125.
4. Brenner, S. (1987). Phosphotransferase sequence homology. Nature 329, 21.
5. Brünger, AT. (1992a). Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475.
6. Brünger, AT. (1992b). X-PLOR Version 3.1: A System for Crystallography and NMR. (New Haven, Connecticut: Yale University Press).
7. Brünger, AT. (1993). Assessment of phase accuracy by cross validation: the free R value. Acta Cryst. D49, 24-36.
8. Chen,C.C., Rahil,J., Pratt, R.F., and Herzberg, O. (1993). Structure of a phosphonate-inhibited β-lactamase: an analog of the tetrahedral transition state/intermediate of β-lactam hydrolysis. J. Mol. Biol. 234, 165-178.
9. Cohen, M.L., Bloom, B.R., Murray, C.J.L., Neu, H.C., Krause, R.M., and Kuntz, I.D. (1992). Drug resistance. Science 257, 1050-1082.
10. Cole, P.A., Grace, M.R., Phillips, R.S., Burn, P., and Walsh, C.T. (1995). The role of the catalytic base in the protein tyrosine kinase Csk. J. Biol. Chem. 270, 22105-22108.
11. Davies, J. (1994). Inactivation of antibiotics and the dissemination of resistance genes. Science 264, 375-382.
12. Doolittle, R.F. (1994). Convergent evolution: the need to be explicit. Trends Biochem. Sci. 19, 15-18.
13. Fourmy, D., Recht, M.I., Blanchard, S.C., and Puglisi, J.D. (1996). Structure of the A site of Escherichia coll 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274, 1371-1376.
14. Gibbs, C.S., and Zoller, M.J. (1991). Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. J. Biol. Chem. 266, 8923-8931.
15. Hanks, S.K., and Hunter, T. (1995). Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9, 576-596.
16. Hanks, S.K., Quinn, A.M., and Hunter, T. (1988). The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42-52.
17. Heinzel, P., Werbitzky, O., Distler, J., and Piepersberg, W. (1988). A second streptomycin resistance gene from Streptomyces griseus codes for streptomycin-3″-phosphotransferase: relationships between antibiotic and protein kinases. Arch. Microbiol. 150, 184-192.
18. Herzberg, O., Kapadia, G., Blanco, B., Smith, T.S., and Coulson, A. (1991). Structural basis for the inactivation of the P54 mutant of β-lactamase from Staphylococcus aureus PC1. Biochemistry 30, 9503-9509.
19. Hubbard,S.R.,Wei, L., Ellis, L., and Hendrickson,W.A. (1994).Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372, 746-754.
20. Imtiaz, U., Billings, E.M., Knox, J.R., and Mobashery, S. (1994). A structure-based analysis of the inhibition of class A β-lactamases by sulbactam. Biochemistry 33, 5728-5738.
21. Johnson, L.N., Noble, M.E.M., and Owen, D.J. (1996). Active and inactive protein kinases: structural basis for regulation. Cell 85, 149-158.
22. Jones, T.A., Bergdoll, M., and Kjeldgaard, M. (1990). A macromolecule modeling environment. In Crystallographic and Modeling Methods in Molecular Design, C.E. Bugg and S.E. Ealick, eds. (New York: Springer Verlag), pp. 189-199.
23. Kabsh, W., and Sander, C. (1983). Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637.
24. Kennelly, P.J., and Potts, M. (1996). Fancy meeting you herel a fresh look at "prokaryotic" protein phosphorylation. J. Bacteriol. 178, 4759-4764.
25. Knighton, D.R., Zheng, J.H., Ten Eyck, L.F., Ashford, V.A., Xuong, N.H.,Taylor, S.S., and Sowadski, J.M. (1991). Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407-414.
26. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24, 946-950.
27. Laskowski, R.A., MacArthur, M.W., Moss, D.S., and Thornton, J.M. (1993). PROCHECK: a prog ram to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283-291.
28. Leatherbarrow, R.J. (1992). Grafit 3.0 ed. (Staines, U.K.: Erithacus Software LTD).
29. 15N heteronuclear NMR studies of Escherichia coli thioredoxin in samples isotopically labeled by residue type. Biochemistry 24, 7263-7268.
30. Lemonick, M.D. (1994). The killers all around: new viruses and drug-resistant bacteria are reversing human victories over infectious disease. Time Magazine 144, 62-69.
31. Lobkovsky, E., Billings, E.M., Moews, P.C., Rahil, J., Pratt, R.F., and Knox, J.R. (1994). Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a β-lactamase transition-state analog. Biochemistry 33, 6762-6772.
32. Madhusudan, Trafny, E.A., Xuong, N.-H., Adams, J.A., Ten Eyck, L.F., Taylor, S.S., and Sowadski, J.M. (1994). cAMP-dependent protein kinase: Crystallographic insights into substrate recognition and phosphotransfer. Prot. Sci. 3, 176-187.
33. Martin, P., Jullien, E., and Courvalin, P. (1988). Nucleotide sequences of Acinetobacter baumannii aphA-6 gene; evolutionary and functional implications of sequence homologies with nucleotide-binding proteins, kinases and other aminoglycoside-modifying enzymes. Mol. Microbiol. 2, 615-625.
34. McKay, G.A., and Wright, G.D. (1995). Kinetic mechanism of aminoglycoside phosphotransferase type Illa: evidence for a Theorell-Chance mechanism. J. Biol. Chem. 270, 24686-24692.
35. McKay, G.A., and Wright, G.D. (1996). Catalytic mechanism of enterococcal kanamycin kinase (APH(3′)-Illa): viscosity, thio, and solvent isotope effects support a Theorell-Chance mechanism. Biochemistry 35, 8680-8685.
36. McKay, G.A., Robinson, R.A., Lane, W.S., and Wright, G.D. (1994a). Active-site labeling of an aminoglycoside antibiotic phosphotransferase (APH(3′)-Illa). Biochemistry 33, 14115-14120.
37. McKay, G.A., Thompson, P.R., and Wright, G.D. (1994b). Broad spectrum aminoglycoside phosphotransferase type III from Enterococcus: overexpression, purification, and substrate specificity. Biochemistry 33, 6936-6944.
38. McPherson, A. (1982). Preparation and Analysis of Protein Crystals. (New York: John Wiley and Sons, Inc.).
39. Merritt, E.A., and Murphy, M.E.P. (1994). RASTER3D version 2.0: a program for photorealistic molecular graphics. Acta Cryst. D50, 869-873.
40. Onishi, H.R., Pelak, B.A., Gerckens, L.S., Silver, L.L., Kahan, F.M., Chen, M.-H., Patchett, A.A., Galloway, S.M., Hyland, S.A., Anderson, M.S., and Raetz, C.R.H. (1996). Antibacterial agents that inhibit lipid A biosynthesis. Science 274, 980-982.
41. Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Meth. Enzymol. 276, 307-326.
42. Owen, D.J., Noble, M.E.M., Garman, E.F., Papgeorgiou, A.C., and Johnson, L.N. (1995). Two structures of the catalytic domain of phosphorylase kinase: an active protein kinase complexed with substrate analogue and product. Structure 3, 467-482.
43. Pedersen, L.C., Benning, M.M., and Holden, H.M. (1995). Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyltransferase. Biochemistry 34, 13305-13311.
44. Piepersberg, W., Distler, J., Heinzel, P., and Perez-Gonzalez, J.-A. (1988). Antibiotic resistance by modification: many resistance genes could be derived from cellular control genes in actinomycetes - a hypothesis. Actinomycetology 2, 83-98.
45. Read, R.J. (1986). Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Cryst. A42,140-149.
46. Robinson, M.J., Harkins, P.C., Zhang, J., Baer, R., Haycock, J.W., Cobb, M.H., and Goldsmith, E.J. (1996). Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5′-triphosphate. Biochemistry 35, 5641-5646.
47. Sakon, J., Liao, H.H., Kanikula, A.M., Benning, M.M., Rayment, I., and Holden, H.M. (1993). Molecular structure of kanamycin nucleotidyltransferase determined to 3.0-Å resolution. Biochemistry 32, 11977-11984.
48. Sarkar, G., and Sommer, S.S. (1990). The "megaprimer" method of site-directed mutagenesis. Biotechniques 8, 404-407.
49. Shaw, K.J., Rather, P.N., Hare, R.S., and Miller, G.H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol.Rev. 57, 138-163.
50. Taylor, S.S., Knighton, D.R., Zheng, J., Ten Eyck, L.F., and Sowadski, J.M. (1992). Structural framework for the protein kinase family. Annu. Rev. Cell Biol. 8, 429-462.
51. Thompson, P.R., Hughes, D.W., and Wright, G.D. (1996a). Mechanism of aminoglycoside 3′-phosphotransferase type Illa: His 188 is not a phosphate-accepting residue. Chem. Biol. 3, 747-755.
52. Thompson, P.R., Hughes, D.W., and Wright, G.D. (1996b). Regiospecificity of aminoglycoside phosphotransferase from Enterococci and Staphylococci (APH(3′)-Illa). Biochemistry 35, 8686-8695.
53. Travis, J. (1994). Reviving the antibiotic miracle? Science 264, 360-362.
54. Travis, J., Culott, E., Nowak, R., Kingman, S., Stone, R., Berkelman, R.L., Bryan, R.T., Osterholm, M.T., LeDuc, J.W., Hughes, J.M., et al. (1994). Frontiers in biotechnology: resistance to antibiotics. Science 264, 360-393.
55. Wang, B.C. (1985). Resolution of phase ambiguity in molecular crystallography. Meth. Enzymol. 115, 90-112.
56. Wells, J.A., Powers, D.B., Bott, R.R., Graycar, T.P., and Estell, D.A. (1987). Designing substrate specificity by protein engineering of electrostatic reactions. Proc. Natl. Acad. Sci. USA 84, 1219-1223.
57. Xu, R.M., Carmel, G., Kuret, J., and Cheng, X. (1996). Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors. Proc. Natl. Acad. Sci. USA 93, 6308-6313.
58. Yamaguchi, H., and Hendrickson, W.A. (1996). Structural basis for activation of human lymphocyte kinase Lck upon tyrosinephosphorylation. Nature 384, 484-489.
59. Zhang, C.-C. (1996). Bacterial signaling involving eukaryotic-type protein kinases. Mol. Microbiol. 20, 9-15.
60. Zhang, F., Strand, A., Robbins, D., Cobb, M.H., and Goldsmith, E.J. (1994). Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature 367, 704-711.